Hoe goed/slecht staat fagron er nu daadwerkelijk voor? Als corporate fagron ons niet informeert, dan gaan we zelf maar op zoek.
Dit geeft informatie over usa fagron dochter JCB uit een eigen bericht aan klanten in Q1 2015.
"You may have noticed that we made some changes to our sales team in December. We had a very successful and talented group of sales people.
Due to conditions out of our control, we had to reorganize our team. This meant, unfortunately, that we released our entire team from service.
We wish the former sales team much success in their future careers. We have seen communication from some of our clients that in fact some of the former sales team members have found opportunities at other sterile compounders. Once again, we wish them and their employers much success in today’s highly regulated environment of sterile compounding.
JCB has never been the “bargain basement” provider in the industry and we don’t intend to be the low-cost provider. We will remain competitive on pricing as much as safety for your patients will allow.
JCB will not sell a product at a price that would indicate corner cutting practices, lack of respect for your business and reputation, or simply to compete with other providers who may not have identified their true value proposition. Think about it...do you really want the cheapest product on the market? Next time one of your vendors (any vendor, not just sterile compounders) comes to you with price as their only value proposition think about all that is missing in that deal."